Potassium-sparing renal effects of trimethoprim and structural analogues

Nephron

Volumn 86, Issue 1, 2000, Pages 70-78

  Gabriëls, Gert ^a,b   Stockem, Esther ^a   Greven, Joachim ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Folate antagonists; Methotrexate; Pentamidine; Pyrimethamine; Renal function; Tetroxoprim; Trimethoprim

Indexed keywords

AMILORIDE; CHLORIDE; FOLIC ACID ANTAGONIST; METHOTREXATE; PENTAMIDINE; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; PYRIMETHAMINE; SODIUM; TETROXOPRIM; TRIAMTERENE; TRIMETHOPRIM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINARY EXCRETION;

EID: 0033828491     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045715     Document Type: Article

References (23)

1. Velazquez H, Perazella MA, Wright FS, Ellison DH: Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 1993; 119:296-301.
2. Kleyman TR, Roberts C, Ling BN: A mechanism for pentamidine-induced hyperkalemia: Inhibition of distal nephron sodium transport. Ann Intern Med 1995;122:103-106.
3. Frick A: Reabsorption of inorganic phosphate in the rat kidney. I. Saturation of transport mechanism. II. Suppression of fractional phosphate reabsorption due to expansion of extracellular fluid volume. Pflügers Arch 1968;304: 351-364.
4. Forster RP, Maes JP: Effect of experimental neurogenic hypertension on renal blood flow and glomerular filtration rates in intact denervated kidneys of unanaesthetized rabbits with adrenal glands demedullated. Am J Physiol 1947;150:534.
5. Endou H, Hosoyamada M: Potassium-retaining diuretics: Aldosterone antagonists; in Greger RF, Knauf H, Mutschler E (eds): Diuretics. Berlin, Springer, 1995, pp 335-361.
6. Kaufman AM, Hellman G, Abramson RG: Renal salt wasting and metabolic acidosis with trimethoprim-sulfamethoxazole therapy. Mt Sinai J Med 1983;50:238-239.
7. Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, Benowitz N, Wofsy CB: Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. J Engl J Med 1990;323:776-782.
8. Greenberg S, Reiser IW, Chou SY: Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy. Am J Kidney Dis 1993;22: 603-606.
9. Canaday DH, Johnson JR: Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole. Ann Intern Med 1994;120:437-438.
10. Modest GA, Price B, Mascoli N: Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole. Ann Intern Med 1994;120:437.
11. Pennypacker LC, Mintzer J, Pitner J: Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole. Ann Intern Med 1994;120:437.
12. Alappan R, Perazella MA, Buller G: Trimethoprim-sulfamethoxazole in standard dose causes hyperkalemia (abstract). J Am Soc Nephrol 1995;6:437.
13. Perazella MA, Mahnensmith RL: Trimethoprim-sulfamethoxazole: Hyperkalemia is an important complication regardless of dose. Clin Nephrol 1996;46:187-192.
14. + channels in A6 distal nephron cells. Kidney Int 1994;45:1070-1076.
15. Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR: Brief report: Trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med 1993;328:703-706.
16. Reiser IW, Chou SY, Brown MI, Porush JG: Reversal of trimethoprim-induced antikaliuresis. Kidney Int 1996;50:2063-2069.
17. Schreiber M, Schlanger LE, Chen CB, Lessan-Pezeshki M, Halperin ML, Patnaik A, Ling BN, Kleyman TR: Antikaliuretic action of trimethoprim is minimized by raising urine pH. Kidney Int 1996;49:82-87.
18. Sands M, Kron MA, Brown RB: Pentamidine: A review. Rev Infect Dis 1985;7:625-634.
19. Lachaal M, Venuto RC: Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med 1989;87:260-263.
20. Peltz S, Hashmi S: Pentamidine-induced severe hyperkalemia. Am J Med 1989;87:698-699.
21. Berns JS, Cohen RM, Stumacher RJ, Rudnick MR: Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. J Am Soc Nephrol 1991;1: 1061-1080.
22. Feddersen A, Sack K: Experimental studies on the nephrotoxicity of pentamidine in rats. J Antimicrob Chemother 1991:28:437-446.
23. Lidman C, Bronner U, Gustafsson LL, Rombo L: Plasma pentamidine concentrations vary between individuals with Pneumocystis carinii pneumonia and the drug is actively secreted by the kidney. J Antimicrob Chemother 1994;33: 803-810.